About Merrimack Pharma (MACK)
Merrimack Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing novel treatments for cancer by targeting biomarker-defined cancers. Its clinical programs include MM-121 (seribantumab), MM-141 (istira... Read more
- USD14.68
- USD14.73
- USD14.68
- USD15.89
- -0.30%
- --
- 76.09k
- 122.99k
- 213M
- 11.53
- 16.40%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
